Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04986657 · ClinicalTrials.gov registry record · NA
Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDS
A NA study of Acute Myeloid Leukemia and Myelodysplastic Syndromes, sponsored by Washington University School of Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 325
- Enrollment target
- 1
- Study location
NCT04986657 is a NA study of Acute Myeloid Leukemia and Myelodysplastic Syndromes that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 325 participants, above the 115-participant average among 306 other Acute Myeloid Leukemia trials with a reported enrollment target (183% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04986657, a NA study of Acute Myeloid Leukemia and Myelodysplastic Syndromes, is actively recruiting participants, sponsored by Washington University School of Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 325 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single institution, prospective study of the whole genome sequencing assay, ChromoSeq. Using prospectively collected patient data, coupled with physician surveys, the investigators seek to determine the feasibility of implementing ChromoSeq in addition to standard genomic testing, for patients with the diagnoses of acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
Conditions Studied
Interventions
- DEVICE ChromoSeq
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 325 participants |
| Start Date | 2021-09-17 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04986657
The ClinicalTrials.gov registry entry for NCT04986657 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 325 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 115-participant average among 306 other Acute Myeloid Leukemia trials with a reported enrollment target (183% higher). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Acute Myeloid Leukemia appearing as the primary indexed condition, and to 1 intervention - of which ChromoSeq is the first listed.
NCT04986657 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT04986657 about?
NCT04986657 is a clinical study titled "Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDS". This is a single institution, prospective study of the whole genome sequencing assay, ChromoSeq. Using prospectively collected patient data, coupled with physician surveys, the investigators seek to determine the feasibility of implementing ChromoSeq in addition to standard genomic testing, for pati...
What is the current status of trial NCT04986657?
This trial is currently recruiting. It is a NA study. The enrollment target is 325 participants. The study started on 2021-09-17. Estimated completion is 2027-12-31.
What conditions does trial NCT04986657 study?
This clinical trial studies the following conditions: Acute Myeloid Leukemia, Myelodysplastic Syndromes, Whole Genome Sequencing.
What interventions are being tested in trial NCT04986657?
The interventions under investigation include: ChromoSeq (DEVICE).
Who is sponsoring clinical trial NCT04986657?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04986657 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Myeloid Leukemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
ONC-LEUK-2406: The Impact of Systematic Financial Navigation in Acute Myeloid Leukemia
RECRUITING · NA
-
A Telehealth Advance Care Planning Intervention
RECRUITING · NA
-
Massage Impact on Sleep in Pediatric Oncology
RECRUITING · NA
-
Home Blood Transfusions
RECRUITING · NA
-
Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/Leukemia
RECRUITING · NA
-
CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.